Schwiebert L M, Schleimer R P, Radka S F, Ono S J
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21224, USA.
Cell Immunol. 1995 Oct 1;165(1):12-9. doi: 10.1006/cimm.1995.1181.
The effect of dexamethasone on human MHC class II expression was examined on various cell types including lymphocytes, monocytes, and epithelial cells. Dexamethasone decreased the surface expression of HLA-DR and -DP, but not HLA-DQ, on lymphocytic cell lines that constitutively express these molecules. In addition, dexamethasome down-regulated the mRNA levels of HLA-DRA, but not of HLA-DQB, in Jijoye cells, a human lymphoblastic cell line. Similarly, dexamethasone decreased HLA-DR expression on epithelial and monocytic cell lines that express HLA-DR upon IFN-gamma treatment. In total, these results suggest that dexamethasone inhibits both constitutive and IFN-gamma-inducible MHC class II expression in several cell types. Moreover, these results indicate that the inhibitory effect of dexamethasone on MHC class II expression is selective for HLA-DR and -DP but not HLA-DQ. Possible mechanisms of dexamethasone-mediated regulation of MHC class II expression are discussed.
在地塞米松对包括淋巴细胞、单核细胞和上皮细胞在内的多种细胞类型上人类主要组织相容性复合体II类(MHC II)表达的影响进行了研究。地塞米松降低了组成性表达这些分子的淋巴细胞系上HLA - DR和 - DP的表面表达,但不影响HLA - DQ的表达。此外,在地塞米松下调了人类淋巴细胞系Jijoye细胞中HLA - DRA的mRNA水平,但未下调HLA - DQB的mRNA水平。同样,地塞米松降低了经γ干扰素处理后表达HLA - DR的上皮细胞系和单核细胞系上的HLA - DR表达。总体而言,这些结果表明地塞米松在几种细胞类型中抑制组成性和γ干扰素诱导的MHC II表达。此外,这些结果表明地塞米松对MHC II表达的抑制作用对HLA - DR和 - DP具有选择性,而对HLA - DQ无选择性。文中还讨论了地塞米松介导的MHC II表达调控的可能机制。